(Q40206879)

18 September 2017

Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil (English)

1 reference

18 September 2017

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

Alexandre Ribeiro Fernandes

3 June 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Ana Luiza Braz Pavão

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Patrícia Mouta Nunes de Oliveira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Paulo Roberto Gomes dos Santos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Sandra Maria D Carvalho

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Renate Mohrdieck

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Helena Keico Sato

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Patricia Mandali de Figueiredo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Vanessa Dos Reis von Doellinger

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Maria da Luz Fernandes Leal

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Akira Homma

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Maria de Lourdes S Maia

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

0 references

publication date

14 May 2014

1 reference

18 September 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

6676-6682

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24837504%20AND%20SRC:MED&resulttype=core&format=json

Review of the risks and benefits of yellow fever vaccination including some new analyses

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

THE EFFECT OF PROLONGED CULTIVATION IN VITRO UPON THE PATHOGENICITY OF YELLOW FEVER VIRUS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

The early use of yellow fever virus strain 17D for vaccine production in Brazil--a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

The phylogeny of yellow fever virus 17D vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Genetic variability among yellow fever virus 17D substrains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Yellow Fever Vaccine Post-marketing Surveillance in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Viscerotropic disease following yellow fever vaccination in Peru

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Clinical profile and outcome of children with opsoclonus-myoclonus syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Short report: Incidence of yellow fever vaccine-associated neurotropic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

The reporting sensitivities of two passive surveillance systems for vaccine adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003

Epidemiologic methods in immunization programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.003